A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treatment of fibrosis in patients with systemic sclerosis. A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treat ...
A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treatment of fibrosis in patients with systemic sclerosis. A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treat ...